Henry Hagopian Iii.

Chief Financial Officer, Organogenesis Holdings Inc.

Companies

Annovis Bio, Inc.Chief financial officer Aug 31, 2022 to Nov 22, 2023¹
Organogenesis Holdings Inc.Chief financial officer Aug 25, 2020 to Jan 15, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Annovis Bio, Inc. ANVS1,820 shares³$1.8K at $0.98Nov 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 20, 2023Granted 820 shares at $6.10 of Annovis Bio, Inc.³
Nov 20, 2023Granted 824 shares at $6.07 of Annovis Bio, Inc.⁴
Apr 7, 2023Granted 1,000 shares at $12.61 of Annovis Bio, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAnnovis Bio, Inc., Chief financial officer
2
SEC EDGAROrganogenesis Holdings Inc., Chief financial officer
3
SEC EDGARAnnovis Bio, Inc. shares after the filing of Nov 20, 2023
4
SEC EDGARForm 4 filed Nov 21, 2023
5
SEC EDGARForm 4 filed Apr 11, 2023